\documentclass[11pt]{article}
\usepackage[utf8]{inputenc}

\title{Notes}
%\author{ly1192 }
%\date{November 2019}

\usepackage{gensymb}
\usepackage{adjustbox}
\usepackage{booktabs}
\usepackage{multirow}
\usepackage{longtable, tabularx}
\usepackage{epsfig}
\usepackage{natbib}
\usepackage{amsmath}
\usepackage{bm}
\usepackage{lscape}
\usepackage{amsmath}
\usepackage{array,longtable}


\usepackage{algorithm}
\usepackage{algorithmic}

\usepackage{biblatex} %Imports biblatex package
\addbibresource{cite.bib}

\newcommand{\argmin}{\arg\!\min}

\usepackage{geometry}
\geometry{a4paper,left=2cm,right=2cm,top=1cm,bottom=2cm}


\renewcommand{\baselinestretch}{1.2}

\setlength{\parindent}{4em}
\setlength{\parskip}{1em}


\begin{document}

Notes 

2020-01-18

\noindent
In previous results, we fit the outcome variable with a linear mixed model 
$$Y = S(\beta + b + \Gamma(\alpha^\prime x)) + \epsilon$$
and treat the coefficient 
$z = \beta + b + \Gamma(\alpha^\prime x)$ as a MVN, that is, 
$z| w \sim MVN(\beta + \Gamma(\alpha^\prime x), D)$. 

\noindent
We may also calculate the Kullback-Leibler divergence by using the outcome variables directly, by assuming
$$Y = X(\beta +\Gamma(\alpha^\prime x)) + Z b +  \epsilon$$
$$Y \sim MVN(S(\beta +\Gamma(\alpha^\prime x)) , Z D Z ^\prime)$$
Let's see whether they can return similar results. 


\section{Kullback-Leibler divergence and Purity}

To measure how much the differences are between the treatment group and the placebo group, we apply the Kullback-Leibler (KL) divergence, which measures how one probability distribution $F_1$ is different from another probability distribution $F_2$. 
\begin{equation} \label{eq0}
D_{KL}(F_1 || F_2) = \int_{-\infty}^{+\infty} f_1(x) \log(\frac{f_1(x)}{f_2(x)})dx
\end{equation}
where $f_1$ and $f_2$ denote the probability density functions (pdf) of $F_1$ and $F_2$, separately. The larger the KL divergence between distributions is, the more "pure" the distributions are. 
Besides, $D_{KL}(F_1 || F_2) \geq 0$. Similarly, the $D_{KL}(F_2 || F_1)$ is also always larger than or equals to 0.

\noindent
Based on the Kullback-Leibler divergence, we define the $purity$, which represent how much the differences between the treatment group distribution $F_1$ and the placebo group distribution $F_2$. 
\noindent
We define the puirty function of the summation of two Kullback-Leibuler divergence as 
\begin{equation} \label{eq4}
\begin{aligned}
purity = & D_{KL}(F_1 || F_2) + D_{KL}(F_2 || F_1) \\
 = &\int_{-\infty}^{+\infty} f_1(x) \log(\frac{f_1(x)}{f_2(x)})dx +  \int_{-\infty}^{+\infty} f_2(x) \log(\frac{f_2(x)}{f_1(x)})dx
\end{aligned}
\end{equation}
where 
$$f_1(x) \sim MVN(\bm \mu_1, \bm \Sigma_1)$$
$$f_2(x) \sim MVN(\bm \mu_2, \bm \Sigma_2)$$
Let's calculate the purity value by calculating
$\int f_1 \log f_1, \int f_2 \log f_2, \int f_1 \log f_2$, and $\int f_2 \log f_1$.

\subsubsection*{Part $\int f_1 \log f_1$}

\begin{equation*}
    \begin{aligned}
\int  f_1 \log f_1 = & E_1\big\{ -\frac{n}{2} \log(2\pi) - \frac{1}{2} \log(|\bm \Sigma_1 |) - 
\frac{1}{2}( \bm x - \bm \mu_1 )^{\prime}(\bm \Sigma_1)^{-1}(\bm x - \bm \mu_1)\big \} \\
=&-\frac{n}{2} \log(2\pi) - \frac{1}{2} \log(|\bm \Sigma_1 |)  -\frac{1}{2}E_1[( \bm x - \bm \mu_1 )^{\prime}(\bm \Sigma_1)^{-1}(\bm x - \bm \mu_1)]
\end{aligned}
\end{equation*}
And
$$\begin{aligned}
E_1[( \bm x - \bm \mu_1 )^{\prime}(\bm \Sigma_1)^{-1}(\bm x - \bm \mu_1)] = & E_1 [tr(( \bm x - \bm \mu_1 )^{\prime}(\bm \Sigma_1)^{-1}(\bm x - \bm \mu_1))] \\
= & E_1 [tr \big( (\bm \Sigma_1)^{-1} (\bm x - \bm \mu_1)(\bm x - \bm \mu_1)^\prime \big) ] \\
= & tr \big(E_1[ (\bm \Sigma_1)^{-1} (\bm x - \bm \mu_1)(\bm x - \bm \mu_1)^\prime \big) ] \big) \\
= & tr \big(\Sigma_1^{-1} E_1[(\bm x - \bm \mu_1)(\bm x - \bm \mu_1)^\prime] \big) \\
= & tr \big(\Sigma_1^{-1} \Sigma_1 \big) = tr(\bm I_n) = n
\end{aligned}$$
\noindent
Therefore, 
\begin{equation} \label{eq 5}
    \int f_1 \log f_1 =-\frac{n}{2} \log(2\pi) - \frac{1}{2} \log(|\bm \Sigma_1|) -\frac{n}{2}
\end{equation}

\noindent
Similarly,
\begin{equation} \label{eq 5}
    \int f_2 \log f_2 =-\frac{n}{2} \log(2\pi) - \frac{1}{2} \log(|\bm \Sigma_2|) -\frac{n}{2}
\end{equation}

\subsubsection*{Part $\int f_1 \log f_2$}

$$\begin{aligned}
\int f_1 \log f_2 =  & E_1(-\frac{n}{2} \log(2\pi) - \frac{1}{2}\log(| \bm \Sigma_2 |)  -\frac{1}{2}(\bm x - \mu_2)^\prime \Sigma_2^{-1} (\bm x - \mu_2) )\\
= & -\frac{n}{2} \log(2\pi) - \frac{1}{2}\log(| \bm \Sigma_2 |) - \frac{1}{2} E_1 [(\bm x - \mu_2)^\prime \Sigma_2^{-1} (\bm x - \mu_2)]
\end{aligned}$$
And
$$\begin{aligned} 
& E_1[(\bm x - \bm \mu_2)^{\prime} \bm \Sigma_2^{-1}(x - \bm \mu_2)] \\
= & E_1[(\bm x - \bm \mu_1 + \bm \mu_1 - \bm \mu_2)^{\prime} \bm \Sigma_2^{-1}(\bm x - \bm \mu_1 + \bm \mu_1 - \bm \mu_2)] \\
=& E_1[(\bm x - \bm \mu_1)^{\prime} \bm \Sigma_2^{-1}(\bm x - \bm \mu_1) + (\bm \mu_1 - \bm \mu_2)^{\prime} \bm \Sigma_2^{-1}(\bm x - \bm \mu_1) \\
       & + (\bm x - \bm \mu_1) \bm \Sigma_2^{-1} ( \bm \mu_1 -\bm \mu_2) + (\bm \mu_1 -\bm \mu_2)^{\prime}\bm \Sigma_2^{-1}(\bm \mu_1 - \bm \mu_2)] \\
=& E_1[(\bm x - \bm \mu_1)^{\prime}\bm \Sigma_2^{-1}(\bm x - \bm \mu_1)] + (\bm \mu_1 -\bm \mu_2)^{\prime}\bm \Sigma_2^{-1}E_1(\bm x - \bm \mu_1) + \\
       & E_1(\bm x - \bm \mu_1)^{\prime})\Sigma_2^{-1} (\bm \mu_1 -\bm \mu_2) +  (\bm \mu_1 -\bm \mu_2)^{\prime}\bm \Sigma_2^{-1}(\bm \mu_1 -\bm \mu_2)\\
=&E_1[(\bm x - \bm \mu_1)^{\prime}\bm \Sigma_2^{-1}(\bm x - \bm \mu_1)]  + 0 + 0 +  (\bm \mu_1 - \bm \mu_2)^{\prime}\bm \Sigma_2^{-1}(\bm \mu_1 - \bm \mu_2) \\
       =&  E_1[tr(\bm x - \bm \mu_1)^{\prime}\bm \Sigma_2^{-1}(\bm x - \bm \mu_1))] + (\bm \mu_1 - \bm \mu_2)^{\prime}\bm \Sigma_2^{-1}(\bm \mu_1 - \bm \mu_2)  \\
=& E_1[tr(\bm \Sigma_2^{-1}(\bm x - \bm \mu_1)^{\prime}(\bm x - \bm \mu_1))] + (\bm \mu_1 - \bm \mu_2)^{\prime}\bm \Sigma_2^{-1}(\bm \mu_1 - \bm \mu_2) \\
       =& tr(E_1[\bm \Sigma_2^{-1}(\bm x - \bm \mu_1)^{\prime}(\bm x - \bm \mu_1)]) + (\bm \mu_1 - \bm \mu_2)^{\prime}\bm \Sigma_2^{-1}(\bm \mu_1 - \bm \mu_2) \\
=& tr(\bm \Sigma_2^{-1} E_1[(x - \bm \mu_1)^{\prime}(\bm x - \bm \mu_1)]) + (\bm \mu_1 - \bm \mu_2)^{\prime}\bm \Sigma_2^{-1}(\bm \mu_1 - \bm \mu_2) \\
       =& tr(\bm \Sigma_2^{-1} \bm \Sigma_1) + (\bm \mu_1 - \bm \mu_2)^{\prime}\bm \Sigma_2^{-1}(\bm \mu_1 - \bm \mu_2) 
\end{aligned}$$
Therefore, 
\begin{equation}
    \int f_1 \log f_2 = -\frac{n}{2} \log(2\pi) - \frac{1}{2}\log(| \bm \Sigma_2 |) - \frac{1}{2} \big\{ tr(\bm \Sigma_2^{-1} \bm \Sigma_1) + (\bm \mu_1 - \bm \mu_2)^{\prime}\bm \Sigma_2^{-1}(\bm \mu_1 - \bm \mu_2) \big\}
\end{equation}
Similarly,
\begin{equation}
    \int f_2 \log f_1 = -\frac{n}{2} \log(2\pi) - \frac{1}{2}\log(| \bm \Sigma_1 |) - \frac{1}{2} \big\{ tr(\bm \Sigma_1^{-1} \bm \Sigma_2) + (\bm \mu_1 - \bm \mu_2)^{\prime}\bm \Sigma_1^{-1}(\bm \mu_1 - \bm \mu_2) \big\}
\end{equation}
Then the purity is 
\begin{equation}
\begin{aligned}
& \int f_1 \log f_1  + \int f_2 \log f_2  - \int f_2 \log f_1 -\int f_1 \log f_2 \\
= & -\frac{n}{2} \log(2\pi) - \frac{1}{2} \log(|\bm \Sigma_1|) -\frac{n}{2} \\
 - & \frac{n}{2} \log(2\pi) - \frac{1}{2} \log(|\bm \Sigma_2|) -\frac{n}{2}\\
- & (-\frac{n}{2} \log(2\pi) - \frac{1}{2}\log(| \bm \Sigma_2 |) - \frac{1}{2} \big\{ tr(\bm \Sigma_2^{-1} \bm \Sigma_1) + (\bm \mu_1 - \bm \mu_2)^{\prime}\bm \Sigma_2^{-1}(\bm \mu_1 - \bm \mu_2) \big\}) \\
- & (-\frac{n}{2} \log(2\pi) - \frac{1}{2}\log(| \bm \Sigma_1 |) - \frac{1}{2} \big\{ tr(\bm \Sigma_1^{-1} \bm \Sigma_2) + (\bm \mu_1 - \bm \mu_2)^{\prime}\bm \Sigma_1^{-1}(\bm \mu_1 - \bm \mu_2) \big\}) \\
= &  -n + \frac{1}{2} tr(\bm \Sigma_1^{-1} \bm \Sigma_2) + \frac{1}{2} tr(\bm \Sigma_2^{-1} \bm \Sigma_1) \\+ & \frac{1}{2} [(\bm \mu_1 - \bm \mu_2)^{\prime}\bm \Sigma_1^{-1}(\bm \mu_1 - \bm \mu_2)] + \frac{1}{2} [(\bm \mu_1 - \bm \mu_2)^{\prime}\bm \Sigma_2^{-1}(\bm \mu_1 - \bm \mu_2)] 
\end{aligned}
\end{equation}

\noindent
Then the purity is defined as 
$-n + \frac{1}{2} tr(\bm \Sigma_1^{-1} \bm \Sigma_2) + \frac{1}{2} tr(\bm \Sigma_2^{-1} \bm \Sigma_1)+  \frac{1}{2} [(\bm \mu_1 - \bm \mu_2)^{\prime}\bm \Sigma_1^{-1}(\bm \mu_1 - \bm \mu_2)] + \frac{1}{2} [(\bm \mu_1 - \bm \mu_2)^{\prime}\bm \Sigma_2^{-1}(\bm \mu_1 - \bm \mu_2)]$ for two normal distributions $f_1$, $f_2$ with mean $\mu_1, \mu_2$ respectively and covariance matrix $\Sigma_1, \Sigma_2$ respectively. 



\noindent
Back to our model, when 
we fit the coefficients of the LME, i,e, 
$$z = \bm \beta + \bm b + \bm \Gamma (\bm {\alpha^\prime x})$$ as multivariate normal distributions and plug in equation (7), we can get our purity function: 
\begin{equation} \label{eq7}
    Purity( \alpha)=  A_0 + A_1 \bm \mu_x ^\prime \bm \alpha + \frac{A_2}{2} \big[\bm \alpha^\prime \bm \Sigma_x \bm \alpha + \bm \alpha^\prime \bm \mu_x \bm \mu_x^\prime \bm \alpha \big]
\end{equation}
where $$A_0 = -q + \frac{1}{2}tr(\bm D_2^{-1} \bm D_1) +\frac{1}{2}tr(\bm D_1^{-1} \bm D_2)+ \frac{1}{2} (\bm \beta_1 - \bm \beta_2) ^{\prime}  (\bm D_1^{-1} + \bm D_2^{-1}) (\bm \beta_1 - \bm \beta_2)$$
$$A_1 = (\bm \beta_1 - \bm \beta_2) ^{\prime}  (\bm D_1^{-1} + \bm D_2^{-1}) (\bm \Gamma_1 - \bm \Gamma_2)$$
$$A_2 = (\bm \Gamma_1 - \bm \Gamma_2)  \big) ^{\prime}(\bm D_1^{-1} + \bm D_2^{-1}) \big((\bm \Gamma_1 - \bm \Gamma_2)$$

\noindent
When we fit  the outcome as normal distribution and plug in the equation (7), we can simply replace the $\bm \beta$ in equation (8) as $\bm S \bm \beta$; replace $\bm \Gamma$ as $\bm S \bm \Gamma$; replace $\bm D$ as $\bm Z \bm D \bm Z^\prime$


\noindent
Replace $\bm \mu_1$, $\bm \mu_2$ with $\bm X (\bm \beta_1+ \bm \Gamma_1 (\bm \alpha^\prime \bm x))$, and $\bm X (\bm \beta_2+ \bm \Gamma_2 (\bm \alpha^\prime \bm x))$. Replace $\bm D_1, \bm D_2$ with $Z \bm D_1 \bm Z^\prime$, $Z \bm D_2 \bm Z^\prime$. Then the purity function is 
\begin{equation}
    Purity( \alpha)=  B_0 + B_1 \bm \mu_x ^\prime \bm \alpha + \frac{B_2}{2} \big[\bm \alpha^\prime \bm \Sigma_x \bm \alpha + \bm \alpha^\prime \bm \mu_x \bm \mu_x^\prime \bm \alpha \big]
\end{equation}
where 
$$\begin{aligned}
B_0 = & -q + \frac{1}{2}tr(\bm (Z \bm D_2 \bm Z^\prime)^{-1} \bm ( \bm Z \bm D_1 \bm Z^\prime)) +\frac{1}{2}tr(\bm (\bm  Z \bm D_1 \bm Z^\prime)^{-1} \bm ( \bm  Z \bm D_2 \bm Z^\prime)) \\+ & \frac{1}{2} (\bm S \bm \beta_1 - \bm S \bm \beta_2) ^{\prime}  (\bm ( \bm  Z \bm D_1 \bm Z^\prime)^{-1} + \bm ( \bm  Z \bm D_2 \bm Z^\prime)^{-1}) (\bm S \bm \beta_1 - \bm S \bm \beta_2)\end{aligned}$$
$$B_1 = (\bm S \bm \beta_1 - \bm S \bm \beta_2) ^{\prime}  (\bm (\bm  Z \bm D_1 \bm Z^\prime)^{-1} + \bm (\bm  Z \bm D_2 \bm Z^\prime)^{-1}) (\bm S \bm \Gamma_1 - \bm S \bm \Gamma_2)$$
$$B_2 = (\bm S \bm \Gamma_1 - \bm S \bm \Gamma_2)  \big) ^{\prime}(\bm (\bm  Z \bm D_1 \bm Z^\prime)^{-1} + \bm (\bm  Z \bm D_2 \bm Z^\prime)^{-1}) \big((\bm S \bm \Gamma_1 - \bm S\bm \Gamma_2)$$



%\subsection{Linear Mixed Model with Linear Combination of Baseline Biosignatures}

%\subsubsection{Purity Calculation}

%\subsection{Optimization of $\alpha$}




\end{document}
